Hozibal K, Wukich DK: Diabetic foot infections: current concept review. Diabet Foot Ankle 3: 2012.
Kruse I, Edelman S: Evaluation and treatment of diabetic foot ulcers. Clin Diabetes 24: 91, 2006.
Gupta S, Bates-Jensen B, Gabriel A, et al: Differentiating negative pressure wound therapy devices: an illustrative case series. Wounds 19: 1, 2007.
Zamboni WA, Wong HP, Stephenson LL, et al: Evaluation for hyperbaric oxygen for diabetic wounds: a prospective study. Undersea Hyperb Med 24: 175, 1997.
Wainwright DJ, Bury SB: Acellular dermal matrix in the management of the burn patient. Aesthet Surg J 31: 13S, 2011.
Wong I, Burns J, Snyder S: Arthroscopic GraftJacket repair of rotator cuff tears. J Shoulder Elbow Surg 19: 104, 2010.
Wilkins R: Acellular dermal graft augmentation in quadriceps tendon rupture repair. Curr Orthop Pract 21: 315, 2010.
Lee D: Achilles tendon repair with acellular tissue graft augmentation in neglected ruptures. J Foot Ankle Surg 46: 451, 2007.
Sbitany H, Sandeen S, Amalfi A, et al: Acellular dermis-assisted prosthetic breast reconstruction versus complete submuscular coverage: a head-to-head comparison of outcomes. Plast Reconstr Surg 124: 1735, 2009.
Capito AE, Tholpady SS, Agrawal H, et al: Evaluation of host tissue integration, revascularization, and cellular infiltration within various dermal substrates. Ann Plast Surg 68: 495, 2012.
Chen SG, Tzeng YS, Wang CH: Treatment of severe burn with DermACELL, an acellular dermal matrix. Int J Burns Trauma 2: 105, 2012.
Yonehiro L, Burleson G, Sauer V: Use of a new acellular dermal matrix for treatment of non-healing wounds in the lower extremities of the diabetic patient. Wounds 25: 340, 2013.
Peng MM, Kurt S, Johannes RS: Adverse outcomes from hospital-acquired infection in Pennsylvania cannot be attributed to increased risk on admission. Am J Med Qual 21: 17S, 2006.
Samsell B, Moore MA: Use of controlled low dose gamma irradiation to sterilize allograft tendons for ACL reconstruction: biomechanical and clinical perspective. Cell Tissue Bank 13: 217, 2012.
Moore MA: Inactivation of enveloped and non-enveloped viruses on seeded human tissues by gamma irradiation. Cell Tissue Bank 13: 401, 2012.
Vashi C: Clinical outcomes for breast cancer patients undergoing mastectomy and reconstruction with use of DermACELL, a sterile, room temperature acellular dermal matrix. Plast Surg Int 2014: 704323, 2014.
Bullocks JM: DermACELL: a novel and biocompatible acellular dermal matrix in tissue expander and implant-based breast reconstruction. Eur J Plast Surg 37: 529, 2014.
Roussalis JL: Novel use of an acellular dermal matrix allograft to treat a chronic scalp wound with bone exposure: a case study. Int J Burns Trauma 4: 49, 2014.
Shitrit S, Ramon Y, Bertasi G: Use of a novel acellular dermal matrix allograft to treat complex trauma wound: a case study. Int J Burns Trauma 4: 62, 2014.
Winters CL, Brigido SA, Liden BA, et al: A multicenter study involving the use of a human acellular dermal regenerative tissue matrix for the treatment of diabetic lower extremity wounds. Adv Skin Wound Care 21: 375, 2008.
Reyzelman A, Crews RT, Moore JC: Clinical effectiveness of an acellular dermal regenerative tissue matrix compared to standard wound management in healing diabetic foot ulcers: a prospective, randomised, multicentre study. Int Wound J 6: 196, 2009.
Landsman A, Cook J, Cook E, et al: Retrospective cohort study of 188 patients treated with a biologically active human skin allograft (TheraSkin) for diabetic foot and venous leg ulcers. Foot Ankle Spec 4: 29, 2011.
Niezgoda JA, Van Gils CC, Fryberg RG, et al: Randomized clinical trial comparing OASIS Wound Matrix to Regranex Gel for diabetic foot ulcers. Adv Skin Wound Care 18: 258, 2005.
Iorio ML, Goldstein J, Adams M, et al: Use of Integra, a bilayered human skin equivalent, in the treatment of diabetic foot ulcers. Plast Reconstr Surg 124: 33, 2009.
Diabetes often causes ulcers on the feet of diabetic patients. A 56-year-old, insulin-dependent, diabetic woman presented to the wound care center with a Wagner grade 3 ulcer of the right heel. She reported a 3-week history of ulceration with moderate drainage and odor and had a history of ulceration and osteomyelitis in the contralateral limb. Rigorous wound care, including hospitalization; surgical incision and drainage; intravenous antibiotic drug therapy; vacuum-assisted therapy; and a new room temperature, sterile, human acellular dermal matrix graft were used to heal the wound, save her limb, and restore her activities of daily living. This case presentation involves alternative treatment of a diabetic foot ulcer with this new acellular dermal matrix, DermACELL.